515 related articles for article (PubMed ID: 21901321)
41. Ethanol elevates accumbal dopamine levels via indirect activation of ventral tegmental nicotinic acetylcholine receptors.
Ericson M; Molander A; Löf E; Engel JA; Söderpalm B
Eur J Pharmacol; 2003 Apr; 467(1-3):85-93. PubMed ID: 12706460
[TBL] [Abstract][Full Text] [Related]
42. Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections.
Ferrari R; Le Novère N; Picciotto MR; Changeux JP; Zoli M
Eur J Neurosci; 2002 Jun; 15(11):1810-8. PubMed ID: 12081661
[TBL] [Abstract][Full Text] [Related]
43. α6-Containing nicotinic acetylcholine receptors in midbrain dopamine neurons are poised to govern dopamine-mediated behaviors and synaptic plasticity.
Berry JN; Engle SE; McIntosh JM; Drenan RM
Neuroscience; 2015 Sep; 304():161-75. PubMed ID: 26210579
[TBL] [Abstract][Full Text] [Related]
44. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei.
Klink R; de Kerchove d'Exaerde A; Zoli M; Changeux JP
J Neurosci; 2001 Mar; 21(5):1452-63. PubMed ID: 11222635
[TBL] [Abstract][Full Text] [Related]
45. Prefrontal beta2 subunit-containing and alpha7 nicotinic acetylcholine receptors differentially control glutamatergic and cholinergic signaling.
Parikh V; Ji J; Decker MW; Sarter M
J Neurosci; 2010 Mar; 30(9):3518-30. PubMed ID: 20203212
[TBL] [Abstract][Full Text] [Related]
46. β2* nAChRs on VTA dopamine and GABA neurons separately mediate nicotine aversion and reward.
Grieder TE; Besson M; Maal-Bared G; Pons S; Maskos U; van der Kooy D
Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25968-25973. PubMed ID: 31776253
[TBL] [Abstract][Full Text] [Related]
47. Nicotine withdrawal in the rat: role of alpha7 nicotinic receptors in the ventral tegmental area.
Nomikos GG; Hildebrand BE; Panagis G; Svensson TH
Neuroreport; 1999 Mar; 10(4):697-702. PubMed ID: 10208533
[TBL] [Abstract][Full Text] [Related]
48. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine.
Picciotto MR; Zoli M; Rimondini R; Léna C; Marubio LM; Pich EM; Fuxe K; Changeux JP
Nature; 1998 Jan; 391(6663):173-7. PubMed ID: 9428762
[TBL] [Abstract][Full Text] [Related]
49. Distinctive nicotinic acetylcholine receptor functional phenotypes of rat ventral tegmental area dopaminergic neurons.
Yang K; Hu J; Lucero L; Liu Q; Zheng C; Zhen X; Jin G; Lukas RJ; Wu J
J Physiol; 2009 Jan; 587(2):345-61. PubMed ID: 19047205
[TBL] [Abstract][Full Text] [Related]
50. Preclinical evidence that activation of mesolimbic alpha 6 subunit containing nicotinic acetylcholine receptors supports nicotine addiction phenotype.
Brunzell DH
Nicotine Tob Res; 2012 Nov; 14(11):1258-69. PubMed ID: 22492084
[TBL] [Abstract][Full Text] [Related]
51. Exposure of nicotine to ventral tegmental area slices induces glutamatergic synaptic plasticity on dopamine neurons.
Jin Y; Yang K; Wang H; Wu J
Synapse; 2011 Apr; 65(4):332-8. PubMed ID: 20730803
[TBL] [Abstract][Full Text] [Related]
52. Differential roles of α6β2* and α4β2* neuronal nicotinic receptors in nicotine- and cocaine-conditioned reward in mice.
Sanjakdar SS; Maldoon PP; Marks MJ; Brunzell DH; Maskos U; McIntosh JM; Bowers MS; Damaj MI
Neuropsychopharmacology; 2015 Jan; 40(2):350-60. PubMed ID: 25035086
[TBL] [Abstract][Full Text] [Related]
53. Striatal dopamine transmission is reduced after chronic nicotine with a decrease in α6-nicotinic receptor control in nucleus accumbens.
Exley R; Clements MA; Hartung H; McIntosh JM; Franklin M; Bermudez I; Cragg SJ
Eur J Neurosci; 2013 Oct; 38(7):3036-43. PubMed ID: 23841846
[TBL] [Abstract][Full Text] [Related]
54. Mysterious alpha6-containing nAChRs: function, pharmacology, and pathophysiology.
Yang KC; Jin GZ; Wu J
Acta Pharmacol Sin; 2009 Jun; 30(6):740-51. PubMed ID: 19498417
[TBL] [Abstract][Full Text] [Related]
55. Nicotine persistently activates ventral tegmental area dopaminergic neurons via nicotinic acetylcholine receptors containing α4 and α6 subunits.
Liu L; Zhao-Shea R; McIntosh JM; Gardner PD; Tapper AR
Mol Pharmacol; 2012 Apr; 81(4):541-8. PubMed ID: 22222765
[TBL] [Abstract][Full Text] [Related]
56. Mechanism-based medication development for the treatment of nicotine dependence.
Xi ZX; Spiller K; Gardner EL
Acta Pharmacol Sin; 2009 Jun; 30(6):723-39. PubMed ID: 19434058
[TBL] [Abstract][Full Text] [Related]
57. Alpha7 nicotinic acetylcholine receptors modulate motivation to self-administer nicotine: implications for smoking and schizophrenia.
Brunzell DH; McIntosh JM
Neuropsychopharmacology; 2012 Apr; 37(5):1134-43. PubMed ID: 22169946
[TBL] [Abstract][Full Text] [Related]
58. In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence.
Jackson A; Bagdas D; Muldoon PP; Lichtman AH; Carroll FI; Greenwald M; Miles MF; Damaj MI
Neuropharmacology; 2017 May; 118():38-45. PubMed ID: 28279662
[TBL] [Abstract][Full Text] [Related]
59. Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area.
Laviolette SR; van der Kooy D
Mol Psychiatry; 2003 Jan; 8(1):50-9, 9. PubMed ID: 12556908
[TBL] [Abstract][Full Text] [Related]
60. Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain.
Metaxas A; Al-Hasani R; Farshim P; Tubby K; Berwick A; Ledent C; Hourani S; Kitchen I; Bailey A
Neuropharmacology; 2013 Aug; 71():228-36. PubMed ID: 23583933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
